Andrographolide Inhibits Epstein–Barr Virus Lytic Reactivation in EBV-Positive Cancer Cell Lines through the Modulation of Epigenetic-Related Proteins

Reactivation of Epstein–Barr virus (EBV) is associated with EBV-associated malignancies and is considered to be a benefit target for treatment. Andrographolide is claimed to have antiviral and anti-tumor activities. Therefore, this study aimed to investigate the effect of andrographolide on the inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Malat, Praphatson, Ekalaksananan, Tipaya, Heawchaiyaphum, Chukkris, Suebsasana, Supawadee, Roytrakul, Sittiruk, Yingchutrakul, Yodying, Pientong, Chamsai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316603/
https://www.ncbi.nlm.nih.gov/pubmed/35889536
http://dx.doi.org/10.3390/molecules27144666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316603/
https://www.ncbi.nlm.nih.gov/pubmed/35889536
http://dx.doi.org/10.3390/molecules27144666

Ejemplares similares